Allergy/Imm

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Szema AM et al. - Biotechnology in the form of novel but currently available and in-practice medical devices, as well as new therapeutic agents, have expanded the armamentarium for safely managing patients with HAE pre- and intraoperatively.

Related Articles

Human C1-Esterase Inhibitor Concentrate (Berinert(R))
BioDrugs, 11/10/09    Relevance Score: 87%

Anaphylaxis and angioedema
Dermatology in Practice, 10/09/09    Relevance Score: 87%

Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
Journal of Allergy and Clinical Immunology, 10/07/09    Relevance Score: 87%

Supraglottic swelling may not correlate with tongue swelling in angiotensin converting enzyme inhibitor-induced angioedema
The Laryngoscope, 11/06/09    Relevance Score: 84%

Pathogenesis and laboratory diagnosis of hereditary angioedema
Allergy and Asthma Proceedings, 10/09/09    Relevance Score: 84%

Today in Surgery/Transplantation...keeping you current

Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival
Nephrology Dialysis Transplantation, 12/04/09

Therapy with Nonglycosaminoglycan-Binding Mutant CCL7: A Novel Strategy to Limit Allograft Inflammation
American Journal of Transplantation, 12/03/09

Intact LFA-1 deactivation promotes T-cell activation and rejection of cardiac allograft
International Immunology, 12/02/09